0001410578-15-000378.txt : 20150803 0001410578-15-000378.hdr.sgml : 20150801 20150803162147 ACCESSION NUMBER: 0001410578-15-000378 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20150803 DATE AS OF CHANGE: 20150803 GROUP MEMBERS: PATRICK G. G. DEAR GROUP MEMBERS: POLYGON CONVERTIBLE OPPORTUNITY MASTER FUND GROUP MEMBERS: POLYGON GLOBAL PARTNERS LLP GROUP MEMBERS: POLYGON GLOBAL PARTNERS LP GROUP MEMBERS: READE E. GRIFFITH GROUP MEMBERS: TFG ASSET MANAGEMENT L.P SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INOTEK PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001281895 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88750 FILM NUMBER: 151022621 BUSINESS ADDRESS: STREET 1: 131 HARTWELL AVE STREET 2: 1ST FLOOR, SUITE 105 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-676-2100 MAIL ADDRESS: STREET 1: 131 HARTWELL AVE STREET 2: 1ST FLOOR, SUITE 105 CITY: LEXINGTON STATE: MA ZIP: 02421 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Polygon Management Ltd. CENTRAL INDEX KEY: 0001515070 IRS NUMBER: 980646182 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: PO BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 212-359-7356 MAIL ADDRESS: STREET 1: PO BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 SC 13G 1 a15-16800_1sc13g.htm SC 13G

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934
(Amendment No.     )*

 

Inotek Pharmaceuticals Corporation

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

45780V102

(CUSIP Number)

July 23, 2015

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 



 

CUSIP No. 45780V102

 

 

1.

Names of Reporting Persons
Polygon Convertible Opportunity Master Fund

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

x

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Cayman Islands

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
1,111,111 (See Item 4(a))

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
1,111,111 (See Item 4(a))

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,111,111 (See Item 4(a))

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
6.372%

 

 

12.

Type of Reporting Person (See Instructions)
OO

 

2



 

CUSIP No. 45780V102

 

 

1.

Names of Reporting Persons
Polygon Management Ltd.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

x

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Cayman Islands

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
1,111,111 (See Item 4(a))

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
1,111,111 (See Item 4(a))

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,111,111 (See Item 4(a))

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
6.372%

 

 

12.

Type of Reporting Person (See Instructions)
OO

 

3



 

CUSIP No. 45780V102

 

 

1.

Names of Reporting Persons
Polygon Global Partners LP

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

x

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Delaware

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
1,111,111 (See Item 4(a))

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
1,111,111 (See Item 4(a))

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,111,111 (See Item 4(a))

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
6.372%

 

 

12.

Type of Reporting Person (See Instructions)
PN

 

4



 

CUSIP No. 45780V102

 

 

1.

Names of Reporting Persons
Polygon Global Partners LLP

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

x

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
United Kingdom

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
1,111,111 (See Item 4(a))

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
1,111,111 (See Item 4(a))

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,111,111 (See Item 4(a))

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
6.372%

 

 

12.

Type of Reporting Person (See Instructions)
PN

 

5



 

CUSIP No. 45780V102

 

 

1.

Names of Reporting Persons
TFG Asset Management L.P.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

x

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Cayman Islands

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
1,111,111 (See Item 4(a))

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
1,111,111 (See Item 4(a))

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,111,111 (See Item 4(a))

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
6.372%

 

 

12.

Type of Reporting Person (See Instructions)
IA

 

6



 

CUSIP No. 45780V102

 

 

1.

Names of Reporting Persons
Patrick G. G. Dear

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

x

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
United Kingdom

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
1,111,111 (See Item 4(a))

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
1,111,111 (See Item 4(a))

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,111,111 (See Item 4(a))

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
6.372%

 

 

12.

Type of Reporting Person (See Instructions)
IN

 

7



 

CUSIP No. 45780V102

 

 

1.

Names of Reporting Persons
Reade E. Griffith

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

x

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
United Kingdom

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
1,111,111 (See Item 4(a))

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
1,111,111 (See Item 4(a))

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,111,111 (See Item 4(a))

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
6.372%

 

 

12.

Type of Reporting Person (See Instructions)
IN

 

8



 

Item 1.

 

(a)

Name of Issuer
Inotek Pharmaceuticals Corporation

 

(b)

Address of Issuer’s Principal Executive Offices
131 Hartwell Avenue, Suite 105, Lexington, MA 02421

 

Item 2.

 

(a)

Name of Person Filing

 

(b)

Address of Principal Business Office or, if none, Residence

 

(c)

Citizenship

 

This Schedule 13G is filed on behalf of Polygon Convertible Opportunity Master Fund, Polygon Management Ltd.,  Polygon Global Partners LP, Polygon Global Partners LLP, TFG Asset Management L.P., Mr. Patrick G. G. Dear and Mr. Reade E. Griffith (the “Reporting Persons”).

 

Polygon Convertible Opportunity Master Fund (the “Master Fund”)

Po Box 309

Ugland House

Grand Cayman, E9 KY1-1104

Citizenship: Cayman Islands

 

Polygon Management Ltd. (the “General Partner”)

Po Box 309

Ugland House

Grand Cayman, E9 KY1-1104

Citizenship: Cayman Islands

 

Polygon Global Partners LP (the “US Investment Manager”)

399 Park Avenue

22nd Floor

New York, NY 10022

Citizenship: Delaware

 

Polygon Global Partners LLP (the “UK Investment Manager”)

4 Sloane Terrace

London, X0 SW1X9DQ

United Kingdom

Citizenship: United Kingdom

 

TFG Asset Management L.P. (the “Manager”)

Po Box 309

Ugland House

Grand Cayman, E9 KY1-1104

Citizenship: Cayman Islands

 

Patrick G. G. Dear (“Mr. Dear”)

c/o Polygon Global Partners LLP

4 Sloane Terrace

London, X0 SW1X9DQ

United Kingdom

 

9



 

 

 

Citizenship: United Kingdom

 

Reade E. Griffith (“Mr. Griffith”)

c/o Polygon Global Partners LLP

4 Sloane Terrace

London, X0 SW1X9DQ

United Kingdom

Citizenship: United Kingdom

 

(d)

Title of Class of Securities
Common Stock, $0.01 par value per share, of Inotek Pharmaceuticals Corporation (“Common Stock”).

 

(e)

CUSIP Number
45780V102

 

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)

o

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

 

(b)

o

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

 

(c)

o

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

 

(d)

o

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

 

(e)

o

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

(f)

o

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

(g)

o

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

(h)

o

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i)

o

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

(j)

o

A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J);

 

(k)

o

Group, in accordance with § 240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with

§ 240.13d–1(b)(1)(ii)(J), please specify the type of institution:____________________________

 

10



 

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a)

Amount beneficially owned:   

As of July 23, 2015, each Reporting Person may be deemed to be beneficial owner of 1,111,111 shares of Common Stock issuable to the Master Fund upon conversion of the 5.0% Senior Convertible Notes due 2020 (the “Convertible Bonds”) in the principal amount of $7,000,000 directly owned by the Master Fund.

 

(b)

Percent of class:    

6.372%

 

(c)

Number of shares as to which the person has:

 

 

 

(i)

Sole power to vote or to direct the vote   

0

 

 

(ii)

Shared power to vote or to direct the vote    

1,111,111 (See Item 4(a))

 

 

(iii)

Sole power to dispose or to direct the disposition of   

0

 

 

(iv)

Shared power to dispose or to direct the disposition of   

1,111,111 (See Item 4(a))

 

 

All of the Convertible Bonds are directly held the Master Fund.  The Manager, the US Investment Manager, the UK Investment Manager and the General Partner have voting and dispository control over securities owned by the Master Fund.  Messrs. Dear and Griffith control the Manager, the US Investment Manager, the UK Investment Manager and the General Partner.

 

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   o.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not Applicable

 

Item 8.

Identification and Classification of Members of the Group

See Exhibit 1

 

Item 9.

Notice of Dissolution of Group

Not Applicable

 

11



 

Item 10.

Certification

By signing below each of the undersigned certifies that, to the best of such person’s knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

 

 

 

 

 

 

 

 

Date: August 3, 2015

POLYGON CONVERTIBLE OPPORTUNITY MASTER FUND

 

 

 

 

 

 

 

By

/s/ Michael Humphries

 

Name: Michael Humphries

 

Title: Director

 

 

 

 

 

 

Date: August 3, 2015

POLYGON MANAGEMENT LTD.

 

 

 

 

 

 

 

By

/s/ Reade E. Griffith

 

Name: Reade E. Griffith

 

Title: Authorized Person

 

 

 

 

 

 

Date: August 3, 2015

POLYGON GLOBAL PARTNERS LP

 

 

 

 

 

 

 

By

/s/ Reade E. Griffith

 

Name: Reade E. Griffith

 

Title: Principal

 

 

 

 

 

 

Date: August 3, 2015

POLYGON GLOBAL PARTNERS LLP

 

 

 

 

 

 

 

By

/s/ Reade E. Griffith

 

Name: Reade E. Griffith

 

Title: Principal

 

 

 

Date: August 3, 2015

TFG ASSET MANAGEMENT L.P.

 

 

 

By:

Polygon Management Ltd., its general partner

 

 

 

 

By

/s/ Reade E. Griffith

 

Name: Reade E. Griffith

 

Title: Authorized Person

 

 

 

 

 

 

Date: August 3, 2015

/s/ Patrick G. G. Dear

 

Patrick G. G. Dear

 

 

 

 

 

 

Date: August 3, 2015

/s/ Reade E. Griffith

 

Reade E. Griffith

 

 

ATTENTION

 

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

 

12



 

Exhibit Index

 

Exhibit 1 Identification of Members of the Group.

 

Exhibit 2 Joint Filing Agreement, dated as of August 3, 2015, by and among Polygon Convertible Opportunity Master Fund, Polygon Management Ltd., Polygon Global Partners LP, Polygon Global Partners LLP, TFG Asset Management L.P., Mr. Patrick G. G. Dear and Mr. Reade E. Griffith.

 


EX-1 2 a15-16800_1ex1.htm EX-1

Exhibit 1

 

Identification of Members of the Group

 

Polygon Convertible Opportunity Master Fund

 

Polygon Management Ltd.

 

Polygon Global Partners LP

 

Polygon Global Partners LLP

 

TFG Asset Management L.P.

 

Patrick G. G. Dear

 

Reade E. Griffith

 


EX-2 3 a15-16800_1ex2.htm EX-2

Exhibit 2

 

Joint Filing Agreement

 

This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, $0.01 par value per share, of Inotek Pharmaceuticals Corporation, a Delaware corporation, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

 

Date: August 3, 2015

POLYGON CONVERTIBLE OPPORTUNITY MASTER FUND

 

 

 

 

 

 

 

By

/s/ Michael Humphries

 

 

Name: Michael Humphries

 

 

Title: Director

 

 

 

 

 

 

Date: August 3, 2015

POLYGON MANAGEMENT LTD.

 

 

 

 

 

 

 

By

/s/ Reade E. Griffith

 

 

Name: Reade E. Griffith

 

 

Title: Authorized Person

 

 

 

 

 

 

Date: August 3, 2015

POLYGON GLOBAL PARTNERS LP

 

 

 

 

 

 

 

By

/s/ Reade E. Griffith

 

 

Name: Reade E. Griffith

 

 

Title: Principal

 

 

 

 

 

 

Date: August 3, 2015

POLYGON GLOBAL PARTNERS LLP

 

 

 

 

 

 

 

By

/s/ Reade E. Griffith

 

 

Name: Reade E. Griffith

 

 

Title: Principal

 

 

 

Date: August 3, 2015

TFG ASSET MANAGEMENT L.P.

 

 

 

 

By:

Polygon Management Ltd., its general partner

 

 

 

 

By

/s/ Reade E. Griffith

 

 

Name: Reade E. Griffith

 

 

Title: Authorized Person

 

 

 

 

 

 

Date: August 3, 2015

 

/s/ Patrick G. G. Dear

 

 

Patrick G. G. Dear

 



 

Date: August 3, 2015

 

/s/ Reade E. Griffith

 

 

Reade E. Griffith